MAOB and Parkinson disease: MAO can be expressed in two distinct isoforms in humans: MAO-A and MAO-B, each presenting different substrate affinities and tissue distribution; however, MAO-B is considered the main pharmacological target in PD mainly due to its involvement in the dopamine deamination in the brain [106].